Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE1657.850.2 (+0.01 %)
PREV CLOSE () 1657.65
OPEN PRICE () 1659.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1943
TODAY'S LOW / HIGH ()1651.65 1673.20
52 WK LOW / HIGH ()900 1711.95
NSE1658.90-8.2 (-0.49 %)
PREV CLOSE() 1667.10
OPEN PRICE () 1661.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1658.90 (90)
VOLUME 36414
TODAY'S LOW / HIGH() 1650.10 1675.30
52 WK LOW / HIGH ()900.05 1725
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984

Management Info :

Sudhir Vaid - Chairman Sudhir Vaid - Managing Director

Registered Office :

Address : 1482-86 ,Trasad Road,Dholka,
Ahmedabad,
Gujarat-382225

Phone : 079-68138700

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
15Apr Reply To Clarification Sought On Volu
We hereby submit that the company has disclosed all the material informa..
06Mar Concord Biotech informs about updates
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclo..
23Feb Concord Biotech gets GMP for unit II o
Ministry of Health Pharmacy and Poisons Board, Republic of Kenya has com..
23Feb Concord Biotech gains on getting GMP f
Concord Biotech is currently trading at Rs. 1463.65, up by 23.40 points..
09Feb Concord Biotech informs about investor
Pursuant to Regulation 30 of Schedule III Part A of SEBI (Listing Obliga..
Financials
in Millions
QTR Dec 23 ANNUAL
Net Profit745.54
Gross Profit 1000.85
Operating Profit 1141.17
Net Sales
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 8679.45 (4.27%)
M.Cap ( in Cr)
19989.31
Abbott India (BSE)
 26604.35 (0.71%)
M.Cap ( in Cr)
56532.39
Amrutanjan Healthcar (BSE)
 786.60 (12.70%)
M.Cap ( in Cr)
2274.11
NGL Fine-Chem (BSE)
 2634.60 (3.41%)
M.Cap ( in Cr)
1627.66
Dr. Reddy's Lab (BSE)
 6288.30 (1.34%)
M.Cap ( in Cr)
104900.33
Shareholding Pattern
PROMOTERS 44.08%
NON-INSTITUTION 41.03%
MUTUAL FUNDS/UTI 5.15%
FI/BANKS/INSURANCE 2.88%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX74611.11128.33 (0.17%)
NIFTY22648.2043.35 (0.19%)
Dow Jones 37903.2987.37 (0.23%)
Nasdaq 15605.48-52.34 (-0.33%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI